Majid Moarefi, MD
Ophthalmology · Long Beach, CANPI 1275890246
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (51.2%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 30 manufacturers reported payments, led by Glaukos Corporation at 27.7% of the total. Among ophthalmology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 256 payments — averaging $114.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Glaukos Corporation$8K
- Alcon$4K
- Carl Zeiss Meditec USA, Inc.$4K
- Carl Zeiss Meditec, Inc.$2K
- AbbVie$2K
- Bausch & Lomb Americas Inc.$2K
- plus $7K from 24 others
Across 33 payments — averaging $2101.97 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Glaukos Corporation$69K
What the payments were for
- Consulting fees$10,33835%
- Speaking & faculty fees$3,00010%
- Travel & lodging$9043%
- Food & beverage$15,02651%
- Education$50%
- Gifts$550%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Glaukos Corporation | 46 | $8,121 |
| Alcon | 47 | $4,105 |
| Carl Zeiss Meditec USA, Inc. | 12 | $3,769 |
| Carl Zeiss Meditec, Inc. | 7 | $2,499 |
| AbbVie(2 entities) | 18 | $2,255 |
| Bausch & Lomb Americas Inc. | 26 | $2,067 |
| Johnson & Johnson Surgical Vision, Inc. | 16 | $1,650 |
| Alcon Research LLC | 1 | $1,125 |
| Harrow Eye, LLC | 5 | $530 |
| Sight Sciences, Inc. | 12 | $477 |
| Revance Therapeutics, Inc. | 5 | $405 |
| Ivantis, Inc | 3 | $378 |
| Galderma Laboratories, L.p. | 8 | $359 |
| Dompe US, Inc. | 8 | $300 |
| Rxsight Inc | 7 | $280 |
| Tarsus Pharmaceuticals, Inc. | 7 | $184 |
| Lumenis BE Inc | 1 | $129 |
| Apellis Pharmaceuticals, Inc. | 1 | $118 |
| Biotissue Holdings Inc. | 3 | $103 |
| Aerie Pharmaceuticals, Inc. | 6 | $97 |
| Sun Pharmaceutical Industries Inc. | 3 | $90 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 4 | $83 |
| Amgen(2 entities) | 2 | $44 |
| Novartis | 2 | $33 |
| Oyster Point Pharma, Inc. | 1 | $25 |
| Ocular Therapeutix, Inc. | 1 | $24 |
| Lumibird Medical Inc. | 1 | $20 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Akorn, Inc. | 1 | $19 |
| Shire North American Group Inc | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- iStent inject Trabecular Micro-Bypass Stent System$3,345
- VisuMax$1,897
- QUATERA 700$1,618
- MEL 90$1,515
- VUITY$1,438
- IOLMaster 700$1,298
- Hydrus Microstent$1,192
- Tecnis Simplicity$1,190
- TENEO$1,145
- VERACITY SURGICAL$1,144
- AcrySof IQ PanOptix$1,079
- enVista Aspire IOL$1,004
- STELLARIS ELITE$1,004
- ARTEVO 800$960
- CALLISTO eye$800
- CIRRUS HD-OCT$800
- CIRRUS 6000 with AngioPlex$800
- NGENUITY$785
- KXL System$744
- iStent inject W$561
How this compares
$29,328 in reported general payments places this provider in the 90th percentile of 2,513 ophthalmology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in Long Beach
- Dan TranLong Beach$232K
- Daniel SchwartzSan Francisco$8M
- Michael BerlinWest Hollywood$5.7M
- Gilbert KlimanMenlo Park$1.5M
- Kuldev SinghStanford$1.5M
- Raymond DouglasBeverly Hills$1.3M
- John AffeldtLoma Linda$1.1M
- Srinivas SaddaPasadena$1M
- Sheri RowenNewport Beach$1M
- Savak TeymoorianLaguna Hills$955K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.